We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Promethera Successfully Enrolls Twenty Patients in its Multicentric Phase I/II Trial

News   Nov 12, 2013

 
Promethera Successfully Enrolls Twenty Patients in its Multicentric Phase I/II Trial
 
 
 

RELATED ARTICLES

Progress in Cochlear Regeneration

News

This research demonstrates a signaling pathway that can be activated by different methods and could represent a new approach to cochlear regeneration and, ultimately, restoration of hearing.

READ MORE

Aspirin Stops Clots After Knee Surgery

News

Putting patients on aspirin following a knee replacement is a safe, cost-effective alternative to anticoagulants, U-M researchers find.

READ MORE

Treating the Prostate with Radiotherapy Improves Survival

News

Treating the prostate with radiotherapy alongside standard treatment led to a 11 percent increase in survival for some men with advanced prostate cancer, shows trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE